A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy - Younossi,Z.M.; Mullen,K.D.; Zakko,W. (J Hepatol, 2001)